KALA BIO, INC. Finance Lease, Liability, Noncurrent
KALA BIO, INC. (KALA) had Finance Lease, Liability, Noncurrent of $737.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2022-05-16
- 2022-03-31: Finance Lease, Liability, Noncurrent $737.00K.
- 2021-12-31: Finance Lease, Liability, Noncurrent $548.00K.
- 2021-09-30: Finance Lease, Liability, Noncurrent $26.66M.
- 2021-06-30: Finance Lease, Liability, Noncurrent $27.06M.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2022-03-31 | $737.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $548.00K 10-Q · filed 2022-05-16 |
| 2021-09-30 | $26.66M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $27.06M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $27.52M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $27.14M 10-K · filed 2022-03-29 |
| 2020-09-30 | $27.55M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $27.93M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $28.30M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $28.67M 10-K · filed 2021-02-25 |
| 2019-09-30 | $29.03M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $29.36M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $29.59M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $28.75M 10-K · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |